A California Assembly committee has unanimously approved a revised bill to create a state workgroup that would be tasked with exploring a regulatory framework to provide therapeutic access to psychedelics like psilocybin and ibogaine.
The Assembly Health Committee passed the legislation from Assemblymember Marie Waldron (R) in a 11-0 vote on Tuesday. It now heads to the Appropriations Committee before potentially moving to the floor.
If the legislature were to enact a regulatory framework as recommended by the workgroup, which would be situated under the California Health and Human Services Agency (CalHHS), the bill would also allow health practitioners to lawfully administer psychedelics in a therapeutic setting.
The version of the legislation that is moving forward has been amended from what Waldron initially introduced last year, which focused exclusively on psychedelics-assisted therapy for military veterans. But the revision comes as the sponsor works with Sen. Scott Wiener (D) on separate legislation to establish a broader therapeutic access model for psychedelics in California.
“California is experiencing a severe mental health crisis with rising rates of anxiety, depression, substance use, post-traumatic stress disorder, suicide and other debilitating conditions,” Waldron said at Tuesday’s hearing. “My bill, AB 941, proposes a solution to this
Read full article on Marijuana Moment
